Kevin Trapp

Kevin Trapp serves as Chief Commercial Officer and is a member of DBV’s Executive Committee, leveraging his extensive portfolio management experience to oversee all global commercial operations. Mr. Trapp rejoined DBV in November 2025, bringing deep institutional knowledge from his prior work with the company in both consulting and executive capacities dating back to 2017. Most recently, Mr. Trapp served as a consultant to the company as Managing Director at Biotech Value Advisors (BVA) where he advised biotechnology boards of directors and executive leadership with product strategy, launch planning, and business evaluation. He built his career at Briston-Myers Squibb (BMS), where he held roles of increasing responsibility across finance, sales, marketing, and general management. During his time at BMS, he managed a ~$4 billion U.S. specialty and primary care portfolio and was a key stakeholder in the planning and subsequent launches of more than 10 products and indications.

Mr. Trapp earned a bachelor’s degree from the University of Connecticut School of Business and completed the General Management Program from the European Centre for Executive Development (CEDEP) at INSEAD.